Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,HR[95%CI],P_value
CASQ2,Calsequestrin-2,Chapter I Certain infectious and parasitic diseases,"Bacterial infection, other or unspecified",22711,96,1.23 [0.88-1.70],0.2214829294441045
CASQ2,Calsequestrin-2,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",23324,173,1.07 [0.81-1.40],0.6536237170588478
CASQ2,Calsequestrin-2,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",23098,1131,0.96 [0.85-1.09],0.536049256109733
CASQ2,Calsequestrin-2,Chapter I Certain infectious and parasitic diseases,Candidiasis,23348,407,1.11 [0.94-1.33],0.226712810199379
CASQ2,Calsequestrin-2,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,22621,2949,1.04 [0.97-1.12],0.2642146142880287
CASQ2,Calsequestrin-2,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),22836,2413,0.91 [0.84-0.99],0.036941278462197
CASQ2,Calsequestrin-2,Chapter I Certain infectious and parasitic diseases,Diarrhoea and gastroenteritis of presumed infectious origin,23114,1143,1.05 [0.95-1.18],0.3423098609137557
CASQ2,Calsequestrin-2,Chapter I Certain infectious and parasitic diseases,Enterocolitis due to Clostridium difficile,23256,76,1.19 [0.82-1.72],0.3634495632095808
CASQ2,Calsequestrin-2,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,21808,671,1.15 [1.02-1.31],0.0286004168153445
CASQ2,Calsequestrin-2,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,21078,775,1.00 [0.87-1.15],0.9848165091443538
CASQ2,Calsequestrin-2,Chapter I Certain infectious and parasitic diseases,Implicit fungal Sepsis,21123,214,1.00 [0.76-1.30],0.9768145409357766
CASQ2,Calsequestrin-2,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,16352,1382,0.94 [0.84-1.05],0.2856711320941033
CASQ2,Calsequestrin-2,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,20938,315,0.94 [0.74-1.18],0.5938831690921995
CASQ2,Calsequestrin-2,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,23296,1325,1.07 [0.97-1.18],0.1831849708849088
CASQ2,Calsequestrin-2,Chapter I Certain infectious and parasitic diseases,Mycoses,23399,458,1.07 [0.90-1.27],0.4183594712538128
CASQ2,Calsequestrin-2,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,22766,799,0.97 [0.84-1.11],0.6303201877826742
CASQ2,Calsequestrin-2,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,23353,738,1.18 [1.04-1.33],0.0097998391280066
CASQ2,Calsequestrin-2,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,22144,173,1.07 [0.81-1.41],0.6289963567494549
CASQ2,Calsequestrin-2,Chapter I Certain infectious and parasitic diseases,Other infectious diseases,23457,37,0.69 [0.30-1.58],0.3771878098144186
CASQ2,Calsequestrin-2,Chapter I Certain infectious and parasitic diseases,Other septicaemia,23267,652,1.18 [1.04-1.34],0.0125007251887164
CASQ2,Calsequestrin-2,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,23254,74,1.07 [0.70-1.62],0.7644807197246954
CASQ2,Calsequestrin-2,Chapter I Certain infectious and parasitic diseases,Other viral diseases,23372,163,0.99 [0.73-1.34],0.9607410267320052
CASQ2,Calsequestrin-2,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",23358,149,1.01 [0.74-1.38],0.9427035804157048
CASQ2,Calsequestrin-2,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,22250,283,0.95 [0.75-1.22],0.6933897317262043
CASQ2,Calsequestrin-2,Chapter I Certain infectious and parasitic diseases,Viral agents as the cause of diseases classified to other chapters,22192,225,0.90 [0.68-1.19],0.446605808310982
CASQ2,Calsequestrin-2,Chapter I Certain infectious and parasitic diseases,Viral and other specified intestinal infections,22071,100,1.15 [0.82-1.62],0.4150091522489828
CASQ2,Calsequestrin-2,Chapter I Certain infectious and parasitic diseases,Viral hepatitis,23434,32,1.05 [0.56-1.99],0.8738040860731774
CASQ2,Calsequestrin-2,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,23390,139,0.94 [0.66-1.33],0.7130297270066193
CASQ2,Calsequestrin-2,Chapter I Certain infectious and parasitic diseases,Viral warts,23290,39,0.60 [0.26-1.40],0.2350318522611404
CASQ2,Calsequestrin-2,Chapter I Certain infectious and parasitic diseases,Zoster [herpes zoster],23321,70,1.04 [0.67-1.63],0.8622066387623358
CASQ2,Calsequestrin-2,Chapter II Neoplasms,Benign lipomatous neoplasm,23214,200,0.91 [0.68-1.22],0.5299012634103266
CASQ2,Calsequestrin-2,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,23365,57,1.10 [0.69-1.75],0.6884873830123297
CASQ2,Calsequestrin-2,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,23358,58,0.83 [0.46-1.49],0.5255389201823228
CASQ2,Calsequestrin-2,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",23204,1028,0.98 [0.86-1.11],0.7021550858498171
CASQ2,Calsequestrin-2,Chapter II Neoplasms,Benign neoplasm of meninges,23433,74,1.00 [0.63-1.57],0.9974775055782192
CASQ2,Calsequestrin-2,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,23399,58,0.81 [0.44-1.47],0.4829140716035814
CASQ2,Calsequestrin-2,Chapter II Neoplasms,Benign neoplasm of other and unspecified endocrine glands,23426,114,1.00 [0.69-1.44],0.9985728173366558
CASQ2,Calsequestrin-2,Chapter II Neoplasms,Benign neoplasm of ovary,23387,148,1.36 [1.09-1.69],0.0063496232306652
CASQ2,Calsequestrin-2,Chapter II Neoplasms,Benign neoplasm: Ascending colon,23437,230,0.81 [0.60-1.10],0.179821210605076
CASQ2,Calsequestrin-2,Chapter II Neoplasms,Benign neoplasm: Caecum,23444,212,0.89 [0.66-1.19],0.4234659757034719
CASQ2,Calsequestrin-2,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",23377,56,0.75 [0.40-1.42],0.3796413086500596
CASQ2,Calsequestrin-2,Chapter II Neoplasms,Benign neoplasm: Descending colon,23442,130,0.84 [0.57-1.24],0.3750500467615928
CASQ2,Calsequestrin-2,Chapter II Neoplasms,Benign neoplasm: Rectum,23403,237,1.09 [0.87-1.38],0.4561131892471851
CASQ2,Calsequestrin-2,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,23357,427,1.02 [0.85-1.23],0.8347575060374741
CASQ2,Calsequestrin-2,Chapter II Neoplasms,Benign neoplasm: Transverse colon,23442,244,1.00 [0.78-1.28],0.9991448925479852
CASQ2,Calsequestrin-2,Chapter II Neoplasms,Carcinoma in situ of breast,19003,118,1.17 [0.87-1.58],0.3033165149179083
CASQ2,Calsequestrin-2,Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",19073,136,0.99 [0.71-1.39],0.9704151563051864
CASQ2,Calsequestrin-2,Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",19070,31,0.36 [0.12-1.06],0.0645089338470651
CASQ2,Calsequestrin-2,Chapter II Neoplasms,"Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)",19095,56,0.89 [0.50-1.59],0.6976986575943063
CASQ2,Calsequestrin-2,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",23396,123,0.79 [0.52-1.20],0.2732133150110934
CASQ2,Calsequestrin-2,Chapter II Neoplasms,"Haemangioma, any site",23397,121,0.80 [0.53-1.22],0.3081987783268872
CASQ2,Calsequestrin-2,Chapter II Neoplasms,Leiomyoma of uterus,22605,487,0.85 [0.70-1.04],0.1080961775044252
CASQ2,Calsequestrin-2,Chapter II Neoplasms,Lung cancer and mesothelioma,16845,271,1.15 [0.94-1.40],0.180271202127432
CASQ2,Calsequestrin-2,Chapter II Neoplasms,Lymphoid leukaemia,19072,33,0.95 [0.46-1.94],0.883178085674461
CASQ2,Calsequestrin-2,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",19191,152,0.84 [0.58-1.20],0.3385786107730242
CASQ2,Calsequestrin-2,Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",19133,94,1.13 [0.79-1.62],0.5045058846676725
CASQ2,Calsequestrin-2,Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",19204,165,1.20 [0.93-1.54],0.1673928433144527
CASQ2,Calsequestrin-2,Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",19099,60,0.89 [0.51-1.55],0.67696637157312
CASQ2,Calsequestrin-2,Chapter II Neoplasms,"Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)",19100,61,0.83 [0.46-1.49],0.5328774062200412
CASQ2,Calsequestrin-2,Chapter II Neoplasms,"Malignant neoplasm of oesophagus, excluding all cancers (controls excluding all cancers)",19088,49,1.33 [0.89-2.01],0.165235883720152
CASQ2,Calsequestrin-2,Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",19161,122,1.18 [0.88-1.59],0.2662595953596628
CASQ2,Calsequestrin-2,Chapter II Neoplasms,"Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)",19128,89,1.18 [0.84-1.66],0.3460233228201973
CASQ2,Calsequestrin-2,Chapter II Neoplasms,"Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)",19110,71,1.27 [0.88-1.81],0.1977012307292224
CASQ2,Calsequestrin-2,Chapter II Neoplasms,"Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)",19073,34,0.59 [0.24-1.47],0.2619884604748622
CASQ2,Calsequestrin-2,Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,19109,70,0.63 [0.33-1.17],0.1423322750367752
CASQ2,Calsequestrin-2,Chapter II Neoplasms,Melanocytic naevi,23230,204,0.95 [0.71-1.26],0.7023137395903103
CASQ2,Calsequestrin-2,Chapter II Neoplasms,Melanocytic naevi of trunk,23421,69,0.81 [0.47-1.40],0.4486966074072931
CASQ2,Calsequestrin-2,Chapter II Neoplasms,Melanoma in situ,19066,75,0.52 [0.27-0.99],0.0481656899002686
CASQ2,Calsequestrin-2,Chapter II Neoplasms,"Non-follicular lymphoma, hilmo, excluding all cancers",19108,69,0.89 [0.53-1.49],0.6499930367900186
CASQ2,Calsequestrin-2,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",19168,129,0.88 [0.60-1.29],0.4979683803881857
CASQ2,Calsequestrin-2,Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",19240,201,1.23 [0.99-1.54],0.0669647433072755
CASQ2,Calsequestrin-2,Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",19119,80,1.03 [0.68-1.58],0.8777293550768146
CASQ2,Calsequestrin-2,Chapter II Neoplasms,Other benign neoplasms of skin,23264,149,0.91 [0.64-1.28],0.5874568174095922
CASQ2,Calsequestrin-2,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",19827,788,0.98 [0.85-1.13],0.7729593350738103
CASQ2,Calsequestrin-2,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",19862,823,0.95 [0.83-1.10],0.5065593442268485
CASQ2,Calsequestrin-2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,23184,330,1.26 [1.07-1.49],0.0062591231314848
CASQ2,Calsequestrin-2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Anaemia in chronic diseases classified elsewhere,21758,83,0.85 [0.52-1.40],0.5245649362739706
CASQ2,Calsequestrin-2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of spleen,22922,68,0.89 [0.53-1.50],0.6652241163790377
CASQ2,Calsequestrin-2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,22589,2521,1.04 [0.96-1.12],0.3226654725038498
CASQ2,Calsequestrin-2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Folate deficiency anaemia,22086,27,0.97 [0.44-2.13],0.9301939665152036
CASQ2,Calsequestrin-2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Idiopathic thrombocytopenic purpura,23115,43,0.35 [0.14-0.87],0.0240370983279665
CASQ2,Calsequestrin-2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,22956,1281,1.05 [0.95-1.17],0.3322058868816605
CASQ2,Calsequestrin-2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,22956,1281,1.05 [0.95-1.17],0.3322058868816605
CASQ2,Calsequestrin-2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified aplastic anaemias,21741,66,1.13 [0.74-1.71],0.5758782140144723
CASQ2,Calsequestrin-2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,23107,1048,0.96 [0.85-1.09],0.5104190526355262
CASQ2,Calsequestrin-2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other coagulation defects,23173,101,1.13 [0.81-1.59],0.4709217382240097
CASQ2,Calsequestrin-2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other diseases of blood and blood-forming organs,22897,43,1.00 [0.55-1.82],0.9902765335236604
CASQ2,Calsequestrin-2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other disorders of white blood cells,22906,52,1.04 [0.61-1.77],0.8789112331385709
CASQ2,Calsequestrin-2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Purpura and other haemorrhagic conditions,23270,198,0.97 [0.73-1.29],0.8205017531522028
CASQ2,Calsequestrin-2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Sarcoidosis,23362,53,0.76 [0.39-1.44],0.3959002222486693
CASQ2,Calsequestrin-2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,"Thrombocytopenia, unspecified",23240,168,1.03 [0.77-1.38],0.8478399909558394
CASQ2,Calsequestrin-2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Vitamin B12 deficiency anaemia,22171,112,1.13 [0.82-1.57],0.4636117729636158
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Acidosis,18899,203,0.93 [0.70-1.25],0.6480499840843512
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Acute alcohol intoxication,22241,55,1.29 [0.91-1.84],0.1561791886172854
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Alcohol dependence,22240,54,0.74 [0.40-1.38],0.3459074903628926
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Alkalosis,18739,43,1.61 [1.15-2.25],0.0052301561342127
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Bipolar affective disorders,21525,53,0.79 [0.42-1.49],0.4750583965212434
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Deficiency of other B group vitamins,21225,210,0.96 [0.73-1.28],0.7970010950985155
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases","Delirium, not induced by alcohol and other psychoactive substances",23084,405,0.97 [0.79-1.19],0.7740882497870045
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in Alzheimer disease,22931,252,0.80 [0.59-1.08],0.1379934415210304
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in other diseases classified elsewhere,22737,58,0.89 [0.50-1.58],0.6942236360600978
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression,23133,1661,0.96 [0.87-1.06],0.4639049433743262
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression or dysthymia,20803,1624,0.98 [0.89-1.08],0.6570490226880266
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of lipoprotein metabolism, unspecified",18743,47,1.37 [0.91-2.07],0.135773380588924
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of thyroid, unspecified",20854,101,1.03 [0.70-1.50],0.8896513882301477
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of calcium metabolism,18940,244,1.00 [0.77-1.28],0.9800805820223158
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of iron metabolism,18737,41,1.24 [0.76-2.01],0.3929931055777683
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,21378,2682,0.97 [0.90-1.05],0.4570633935679432
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of magnesium metabolism,18876,180,0.77 [0.54-1.10],0.1442613075002079
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,19165,469,0.99 [0.82-1.19],0.9160799900512924
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,23375,306,1.00 [0.80-1.25],0.9687528103268268
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of parathyroid gland,23212,143,1.14 [0.85-1.51],0.3799859204449282
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of phosphorus metabolism and phosphatases,18784,88,0.98 [0.64-1.49],0.9193391962168004
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorders of plasma-protein metabolism, not elsewhere classified",18745,49,1.00 [0.57-1.75],0.9936576948981792
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,22710,1957,1.07 [0.99-1.16],0.1092423194270221
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Fluid overload,18867,171,1.13 [0.86-1.48],0.3858564523323141
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperkalaemia,18864,168,0.88 [0.63-1.24],0.47072949342879
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",19153,457,1.10 [0.93-1.30],0.2784243899543892
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,18764,68,1.19 [0.79-1.79],0.4056711975688385
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,23206,137,1.02 [0.74-1.42],0.8985336788099236
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypo-osmolality and hyponatraemia,19220,524,1.14 [0.98-1.33],0.0901000632700774
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypokalaemia,19169,473,1.00 [0.83-1.20],0.989105648907308
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Iron deficiency,21077,62,1.16 [0.75-1.78],0.5018112928155909
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,22707,4011,0.99 [0.93-1.05],0.7676413109344166
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic multinodular goitre,20815,62,0.35 [0.16-0.75],0.0071452089399554
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic single thyroid nodule,20830,77,1.37 [1.00-1.87],0.0487719990292144
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,23294,1758,1.00 [0.91-1.10],0.9360138116748412
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",23298,1757,1.01 [0.92-1.10],0.90324841355006
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other and/or unspecified nontoxic goitre,20824,71,0.93 [0.57-1.53],0.7780324055281449
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other anxiety disorders,23104,1348,1.07 [0.97-1.18],0.1572688089005881
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",19971,1275,1.03 [0.92-1.15],0.6057668192503428
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other disorders of glucose regulation and pancreatic internal secretion,23448,152,0.72 [0.48-1.07],0.1026708242507905
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,22720,41,1.29 [0.81-2.04],0.2826152465766059
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Panic disorder,21871,115,0.89 [0.60-1.33],0.5748772563481452
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Phobic anxiety disorders,21924,168,0.95 [0.70-1.31],0.7691305846937562
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",18910,214,0.90 [0.67-1.20],0.4759507043686596
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,21901,118,0.97 [0.67-1.41],0.8893326854019384
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,1448,37,0.62 [0.26-1.46],0.2730739477978478
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,1541,149,0.79 [0.53-1.19],0.2612383107750725
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,21807,24,0.61 [0.20-1.86],0.3869090630839539
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,1432,22,0.45 [0.17-1.18],0.1051637974206075
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,23053,1270,0.90 [0.80-1.01],0.081465823378883
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Unspecified dementia,22964,285,0.90 [0.69-1.16],0.4122029495050391
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Vitamin D deficiency,21427,412,0.84 [0.67-1.05],0.1214366526385865
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,19302,606,0.96 [0.81-1.14],0.6487131742351955
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",23371,206,0.85 [0.62-1.15],0.2912380209840668
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Abdominal aortic aneurysm (AAA),22573,45,1.28 [0.83-1.99],0.2652930738676581
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Angina pectoris,22158,729,0.90 [0.77-1.06],0.2122866788002398
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Aortic aneurysm,22609,81,0.96 [0.60-1.52],0.8513417122733979
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Arterial embolism and thrombosis of lower extremity artery,22558,30,0.92 [0.42-2.02],0.833164798143464
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,"Atherosclerosis, excluding cerebral and coronary sclerosis",22666,138,1.00 [0.71-1.40],0.9899156507834644
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,15241,1238,0.94 [0.84-1.06],0.3346056676432376
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,AV-block,20580,205,0.95 [0.71-1.26],0.7105978270820326
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",23415,260,0.86 [0.65-1.13],0.2637889229600549
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Cardiac arrest,14109,106,0.93 [0.62-1.39],0.7188429693547831
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Cardiomyopathy,20495,120,0.76 [0.49-1.17],0.2115033849978564
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,"Cardiomyopathy, other and unspecified",20448,73,0.81 [0.48-1.38],0.438808710357179
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Cerebral atherosclerosis,23454,26,2.55 [2.04-3.20],4.050360721567248e-16
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Conduction disorders,20994,619,0.96 [0.81-1.12],0.5924226558223686
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,22681,1261,0.92 [0.82-1.04],0.1678646115448739
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,21106,6213,1.00 [0.95-1.05],0.8981141888622736
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,DVT of lower extremities,22181,219,0.83 [0.62-1.13],0.2420763087258206
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Endocarditis,20420,45,0.78 [0.39-1.57],0.4918551307777573
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,"Heart failure, strict",23375,706,0.90 [0.77-1.06],0.2127992495332457
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Hypertension,21636,5222,1.00 [0.95-1.05],0.954904257119008
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,"Hypertension, essential",21644,5230,1.00 [0.95-1.05],0.935970349268234
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,"Hypertension, portal",23359,34,0.93 [0.45-1.90],0.8368502582215348
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",16562,148,0.78 [0.53-1.16],0.219617035766768
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,16479,65,1.00 [0.61-1.63],0.9985223169669548
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Hypotension,23342,907,0.82 [0.70-0.95],0.0091692136328264
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Intracerebral haemorrhage,22820,81,1.07 [0.70-1.62],0.7565890277575605
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",22855,1426,0.94 [0.84-1.05],0.2440014787987733
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",23192,382,1.03 [0.84-1.25],0.7843269393167226
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Left bundle-branch block,20637,262,1.05 [0.83-1.31],0.7013053828854219
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,23271,517,0.84 [0.69-1.03],0.0916113823438193
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",21846,417,0.96 [0.78-1.17],0.656649884553669
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",23433,76,1.10 [0.73-1.66],0.6400484494181704
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, without ST-elevation",23449,209,0.89 [0.66-1.20],0.4354883114073707
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Oesophageal varices,21995,33,0.58 [0.23-1.46],0.2477596530293828
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Other aneurysm,22578,50,0.73 [0.37-1.46],0.3723679459342862
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Other arrhythmias,20680,305,0.86 [0.67-1.10],0.2353268398226957
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Other arterial embolism and thrombosis,22589,61,0.85 [0.48-1.52],0.5847073439687931
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,22701,173,1.06 [0.80-1.41],0.667361481900733
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Other diseases of pericardium,20521,146,1.08 [0.80-1.44],0.618261506362692
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Other disorders of veins,22037,75,1.08 [0.72-1.63],0.7115184143663916
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Other embolism and thrombosis,22003,41,1.19 [0.72-1.95],0.5018977230602213
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Other intracranial haemorrhages,22403,32,1.00 [0.50-1.99],0.9976228351500198
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Other noninfective disorders of lymphatic vessels and lymph nodes,22092,130,0.84 [0.57-1.24],0.3765073463874059
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,21040,665,1.03 [0.89-1.19],0.7164939534491972
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Other other unspecified disorders of the circulatory system,22472,37,0.80 [0.38-1.71],0.5712774249343349
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,22968,440,1.14 [0.97-1.34],0.1166604608514961
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,22957,278,0.89 [0.68-1.16],0.3820835287855555
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,"Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere",22824,453,0.64 [0.50-0.82],0.0003554619710811
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,14251,248,0.88 [0.67-1.15],0.3433205678688208
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Peripheral artery disease,22761,243,1.10 [0.87-1.38],0.4409244847596835
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),22246,284,0.87 [0.67-1.13],0.2931864673459686
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Pulmonary embolism,23056,377,1.09 [0.90-1.31],0.3828768761060984
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,23387,491,1.04 [0.87-1.23],0.6732642900055296
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Right bundle-branch block,20557,182,0.99 [0.74-1.32],0.9372988918878068
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Secondary right heart disease,22951,272,0.89 [0.68-1.16],0.385110344278366
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Sequelae of cerebrovascular disease,22501,130,0.86 [0.59-1.27],0.4586942459562286
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",23183,444,1.02 [0.84-1.22],0.8736717533041212
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",23161,484,1.04 [0.87-1.23],0.6953547845083659
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Subarachnoid haemorrhage,22793,61,1.07 [0.66-1.71],0.7912399139022062
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Thoracic aortic aneurysm,22564,36,0.84 [0.39-1.79],0.6498577117955078
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Transient ischemic attack,22987,177,1.16 [0.90-1.50],0.2450256341312691
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,22925,171,0.50 [0.32-0.76],0.0014480992128816
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Varicose veins,22335,373,0.97 [0.79-1.19],0.7849437045682568
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Vascular diseases of the intestine,22538,82,1.07 [0.71-1.62],0.7460413651997445
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Venous thromboembolism,23273,599,1.02 [0.87-1.19],0.8231444243738966
CASQ2,Calsequestrin-2,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",23420,192,0.83 [0.60-1.15],0.2632024589779227
CASQ2,Calsequestrin-2,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",20862,1575,1.05 [0.96-1.15],0.287882912388549
CASQ2,Calsequestrin-2,Chapter V Mental and behavioural disorders,Any mental disorder,22951,3664,1.01 [0.95-1.07],0.7899144022952562
CASQ2,Calsequestrin-2,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",23394,224,0.91 [0.69-1.20],0.5044131608360551
CASQ2,Calsequestrin-2,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",20964,1677,0.97 [0.88-1.07],0.5739434299492563
CASQ2,Calsequestrin-2,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",19364,77,1.04 [0.68-1.59],0.8662079934859518
CASQ2,Calsequestrin-2,Chapter V Mental and behavioural disorders,Smoking dependency,23110,1015,1.04 [0.93-1.16],0.5355755562919
CASQ2,Calsequestrin-2,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",20461,1174,1.02 [0.92-1.15],0.6799548142170292
CASQ2,Calsequestrin-2,Chapter V Mental and behavioural disorders,Vascular dementia,23043,91,0.60 [0.34-1.05],0.0746578402838465
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,Alzheimer disease,23455,313,0.93 [0.72-1.18],0.5335653430426522
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,"Alzheimer√ïs disease (Atypical or mixed), excluding more controls",16087,51,0.44 [0.19-1.01],0.053815967786611
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,Bell's palsy,21631,72,0.97 [0.60-1.55],0.8904567101948981
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,22097,538,1.00 [0.85-1.19],0.9535888728111463
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,Cerebral cysts,23111,187,0.94 [0.70-1.27],0.6841596906662546
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,23393,229,1.06 [0.83-1.35],0.6603251408452316
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,Circumscribed brain atrophy,23046,36,0.76 [0.34-1.69],0.5002779279496765
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,Diseases of the myoneural junction and muscle,23444,43,1.07 [0.61-1.86],0.8150173226744716
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,"Disorders of brain, other and unspecified",22969,45,1.25 [0.80-1.96],0.3314484652262036
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,Epilepsy,22212,236,1.06 [0.83-1.34],0.6374100245859868
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,23095,1119,1.02 [0.91-1.14],0.7419667586024716
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,Extrapyramidal and movement disorders,23412,300,0.94 [0.74-1.19],0.6006143850597406
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,Falls/tendency to fall,22923,2449,0.97 [0.90-1.06],0.5332978584930096
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,Generalized epilepsy,23147,40,0.91 [0.46-1.77],0.7727462685618849
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,Hemiplegia,23346,182,1.04 [0.79-1.38],0.7811638145157458
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,Hydrocephalus,22980,56,1.17 [0.75-1.81],0.4858768401386569
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,Inflammatory diseases of the central nervous system,23438,67,1.23 [0.85-1.79],0.2692471617897058
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,Lesion of plantar nerve,21665,106,0.98 [0.67-1.44],0.9280633121801076
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,Lesion of ulnar nerve,21614,55,0.80 [0.43-1.48],0.473670428986966
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,Memory loss,22935,92,1.01 [0.67-1.51],0.9751030744204974
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,Migraine,22409,433,0.79 [0.63-0.99],0.0371860109900438
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",23359,393,0.75 [0.59-0.96],0.0197256284932223
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,Motor neuron disease,16172,112,0.68 [0.43-1.10],0.1157882471963487
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,23264,121,0.90 [0.62-1.32],0.6038715371725603
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",22743,1184,0.93 [0.83-1.05],0.2465340566097565
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,Neurological diseases,22071,3143,0.94 [0.87-1.01],0.0870121901116237
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,Other and unspecified degenerative diseases of nervous system,23132,122,0.79 [0.52-1.22],0.2860350045936428
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",21920,361,0.95 [0.77-1.17],0.6324791879272166
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,"Other and unspecified polyneuropathies, also in other diseases",23408,196,0.82 [0.59-1.14],0.2322430131015249
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,18981,558,0.88 [0.74-1.06],0.1739670856770841
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,Other diseases of spinal cord,22981,57,0.53 [0.25-1.10],0.0863111298018367
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,Other disorders of nervous system,23032,108,0.66 [0.40-1.07],0.0924331106018535
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,Other extrapyramidal and movement disorders in other diseases,23251,139,0.98 [0.70-1.38],0.9112466511589608
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,Other facial nerve disorders,21639,80,0.84 [0.51-1.38],0.4911618705301263
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,Other headache syndromes,22045,69,1.31 [0.93-1.85],0.1244844668472591
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,Other neurological diseases,23353,429,0.93 [0.76-1.14],0.4939296890475197
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,Other sleep disorders,22312,336,1.18 [0.99-1.41],0.0692919016034677
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,Parkinson's disease,23433,141,0.93 [0.65-1.33],0.6999357183901131
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,Postviral fatigue syndrome,22995,71,0.82 [0.48-1.39],0.4561641734957578
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,Restless leg syndrome,23454,75,0.94 [0.58-1.51],0.7884170678266774
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,Sleep apnoea,23306,272,1.17 [0.95-1.42],0.1322946357792789
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,Small fibre neuropathy,23245,33,0.72 [0.30-1.70],0.4483125367450989
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,23445,136,0.70 [0.46-1.07],0.1014746750679245
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,Trigeminal neuralgia,21616,57,0.84 [0.47-1.52],0.5734420362959696
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,Unspecific neurodegenerative disorder,23455,316,0.94 [0.73-1.19],0.5907059567476779
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,Vascular dementia (undefined),23004,88,0.61 [0.34-1.08],0.0917443169232131
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Amblyopia ex anopsia,22943,93,1.05 [0.71-1.55],0.8216017666868773
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Astigmatism,23064,423,1.11 [0.93-1.32],0.2362145843933037
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,23331,141,0.76 [0.51-1.14],0.1820260224436516
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Blepharochalasis,22502,51,1.27 [0.84-1.92],0.2560597008262761
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,22498,47,1.28 [0.84-1.96],0.2541636276235363
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Conjunctivitis (acute, non atopic)",23344,55,0.68 [0.34-1.35],0.2681836041183133
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Corneal degeneration,23214,148,0.83 [0.57-1.21],0.3259044804053339
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",1439,28,0.58 [0.21-1.64],0.3063547305841332
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic neuropathy,1727,54,0.60 [0.29-1.25],0.1722991087312328
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diplopia,22934,84,1.47 [1.14-1.90],0.003060983809915
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,23307,896,0.93 [0.80-1.07],0.2798627297849443
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",23093,642,1.09 [0.95-1.25],0.2295517708023896
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,22709,258,0.96 [0.74-1.23],0.7255944040417646
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",23380,739,1.10 [0.96-1.25],0.1628717141044809
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of optic nerve and visual pathways,23443,62,0.89 [0.52-1.54],0.6752035097334164
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of refraction and accommodation,23317,676,1.10 [0.95-1.26],0.1963448138402191
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of sclera, cornea, iris and ciliary body",23417,351,0.99 [0.80-1.23],0.9554587952830014
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,23376,180,0.74 [0.51-1.06],0.1016076840012484
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ectropion of eyelid,22489,38,0.46 [0.18-1.18],0.1076271125450133
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Entropion and trichiasis of eyelid,22492,41,1.15 [0.67-1.95],0.615861063001041
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Epiphora,22512,61,0.75 [0.40-1.40],0.368170958202651
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,23381,609,1.21 [1.06-1.38],0.0049436951888275
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma suspect,22923,151,1.05 [0.77-1.43],0.7508936060617333
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Hypermetropia,22694,53,1.20 [0.77-1.88],0.4155282575342985
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Iridocyclitis,23150,84,0.87 [0.54-1.40],0.5675416076795632
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Keratitis,23342,276,1.00 [0.79-1.27],0.9897748042760708
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Myopia,22824,183,0.88 [0.63-1.21],0.4194882461466951
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified disorders of vitreous body,23312,116,0.52 [0.31-0.87],0.0127876263226502
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,23169,397,1.16 [0.98-1.38],0.0810468624131009
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,22985,135,1.09 [0.80-1.48],0.5756296562064567
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,21921,2165,1.01 [0.92-1.10],0.8536298302739936
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of cornea,23308,242,0.99 [0.76-1.28],0.9240789755458706
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eye and adnexa,23433,139,1.17 [0.89-1.55],0.2626779832096474
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,22785,334,1.19 [0.99-1.42],0.0576118912883335
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of iris and ciliary body,23121,55,1.07 [0.65-1.75],0.7944741212004469
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of optic [2nd] nerve and visual pathways,23430,49,0.89 [0.48-1.65],0.7109163993883182
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other inflammation of eyelid,22532,81,1.11 [0.75-1.64],0.601740388822476
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,22579,128,1.22 [0.92-1.61],0.1615849758081772
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified retinal disorders,22498,87,1.24 [0.89-1.73],0.2042642798196749
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other strabismus,22695,54,1.28 [0.86-1.91],0.2323986218310581
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Other, unspecified and serous retinal detachments",22465,54,0.82 [0.44-1.53],0.541132040968138
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Primary angle-closure glaucoma,22872,100,1.27 [0.94-1.71],0.1192772737948955
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Primary open-angle glaucoma, strict",22928,156,1.24 [0.96-1.60],0.0924787923826805
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ptosis of eyelid,22562,111,1.19 [0.88-1.62],0.2678273504843557
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal detachment with retinal break,22491,80,0.80 [0.48-1.33],0.3887591610194537
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal vascular occlusion,22467,56,0.90 [0.50-1.60],0.7176581724328737
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,21539,1783,1.12 [1.03-1.22],0.0069550085480505
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Stenosis and insufficiency of lacrimal passages,22528,77,0.85 [0.51-1.41],0.5310257391453914
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,23225,375,1.13 [0.95-1.35],0.168761578971491
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,22889,39,0.94 [0.48-1.85],0.8628799913353309
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),22998,148,0.92 [0.66-1.30],0.6559046235929205
CASQ2,Calsequestrin-2,Chapter VIII Diseases of the ear and mastoid process,Benign paroxysmal vertigo,23237,99,1.03 [0.70-1.50],0.896735269751496
CASQ2,Calsequestrin-2,Chapter VIII Diseases of the ear and mastoid process,Diseases of external ear,23415,94,0.70 [0.42-1.17],0.1776630275753481
CASQ2,Calsequestrin-2,Chapter VIII Diseases of the ear and mastoid process,Diseases of middle ear and mastoid,23351,122,0.75 [0.49-1.15],0.1906045075134521
CASQ2,Calsequestrin-2,Chapter VIII Diseases of the ear and mastoid process,Labyrinthitis,23200,62,1.02 [0.63-1.67],0.92484831045124
CASQ2,Calsequestrin-2,Chapter VIII Diseases of the ear and mastoid process,M¬éni¬ère disease,23203,65,0.71 [0.38-1.31],0.2685614530745391
CASQ2,Calsequestrin-2,Chapter VIII Diseases of the ear and mastoid process,Other disorders of ear,23364,680,0.88 [0.74-1.04],0.1196520363508867
CASQ2,Calsequestrin-2,Chapter VIII Diseases of the ear and mastoid process,Other specified/unspecified hearing loss,23150,466,0.81 [0.65-1.00],0.0522538191810266
CASQ2,Calsequestrin-2,Chapter VIII Diseases of the ear and mastoid process,Sensorineural hearing loss,22784,100,0.76 [0.47-1.22],0.2501877829018075
CASQ2,Calsequestrin-2,Chapter VIII Diseases of the ear and mastoid process,Tinnitus,22756,72,1.09 [0.72-1.66],0.6767130662789524
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Acute pharyngitis,23212,75,1.06 [0.70-1.62],0.7744166245515035
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,23343,206,1.05 [0.81-1.36],0.7127097363564332
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Acute upper respiratory infections of multiple and unspecified sites,23192,55,0.67 [0.34-1.31],0.2414843848081506
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,All influenza,22017,108,1.11 [0.79-1.56],0.5612948515932504
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,All influenza (not pneumonia),22016,107,1.10 [0.77-1.55],0.6049303682680099
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Allergic asthma (mode),16685,111,0.91 [0.61-1.36],0.6359412658141663
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Allergic rhinitis,23331,242,0.67 [0.48-0.92],0.0146429174698084
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",18210,1792,1.00 [0.91-1.10],0.961262036828701
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",18345,1771,1.00 [0.92-1.10],0.9202474428181664
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Bacterial pneumonia (organism specified),23107,114,1.30 [1.00-1.68],0.0539925023945301
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,"Bacterial pneumonia, not elsewhere classified",21970,61,1.30 [0.90-1.87],0.1607154801110947
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Bronchiectasis,20256,345,0.96 [0.77-1.19],0.7083836953094903
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,"Bronchitis, not specified as acute or chronic",19968,57,0.53 [0.25-1.10],0.0879079082479477
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,22470,2559,0.98 [0.90-1.05],0.535378696530981
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,"Chronic rhinitis, nasopharyngitis and pharyngitis",22359,56,0.69 [0.35-1.35],0.2815201128727465
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Chronic sinusitis,22426,123,1.27 [0.97-1.65],0.0794972977813817
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",23306,886,1.04 [0.92-1.18],0.5209201830578277
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Deviated nasal septum,22368,65,1.19 [0.80-1.77],0.3838859269594736
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,21658,4386,0.99 [0.93-1.05],0.6970489116518126
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",22596,293,0.97 [0.77-1.23],0.8230756664628982
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Early onset COPD,22692,272,1.03 [0.83-1.30],0.7696115810039338
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Emphysema,20139,228,0.92 [0.71-1.20],0.5463144717008285
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,22017,197,1.07 [0.82-1.40],0.6012077718091986
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Influenza and pneumonia,23284,1375,1.04 [0.94-1.15],0.4047501128352224
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Interstitial lung disease,22051,231,1.04 [0.80-1.34],0.7731813880725013
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Later onset COPD,22664,614,1.07 [0.92-1.24],0.3977294341001823
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Lung diseases due to external agents,23449,180,0.93 [0.68-1.27],0.6435153276770509
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Nasal polyp,22361,58,1.05 [0.65-1.70],0.842588187238264
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,23255,793,0.97 [0.84-1.12],0.6881382575102788
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Other diseases of pleura,23294,1479,1.01 [0.92-1.12],0.7974108049539468
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,22976,673,0.92 [0.78-1.08],0.2954942219781229
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Other pleural conditions,21849,34,0.89 [0.42-1.87],0.7577382586658741
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,23381,293,1.06 [0.85-1.31],0.6097261969659113
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,23379,1005,1.01 [0.89-1.14],0.8702457505052182
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Pleural effusion,22518,703,1.04 [0.90-1.20],0.6192005248909076
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Pleural plaque,21856,41,0.59 [0.25-1.36],0.2145492132696158
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",23076,1167,1.02 [0.91-1.14],0.7274587210765628
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Pneumonitis due to solids and liquids,23424,155,0.82 [0.57-1.19],0.302043749643882
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Pneumothorax,21901,86,0.81 [0.49-1.34],0.4127978505702928
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Pollen allergy,23430,203,0.66 [0.46-0.94],0.0202594979585992
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Pulmonary oedema,23142,54,0.93 [0.53-1.65],0.8062815197693398
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Respiratory insufficiency,16618,44,0.89 [0.47-1.70],0.7342067120040272
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,23236,774,0.98 [0.85-1.13],0.8010097645779826
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Vasomotor and allergic rhinitis,22545,242,0.67 [0.48-0.93],0.0151213681912494
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Viral pneumonia,22091,182,0.94 [0.69-1.27],0.6754383927384765
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,"Viral pneumonia (unknown virus, not influenza)",23116,145,0.96 [0.69-1.34],0.8034713860464363
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,11308,89,1.04 [0.70-1.55],0.8468939410233969
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,16779,36,1.21 [0.72-2.03],0.4721527763840298
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Acute appendicitis,23289,120,0.98 [0.69-1.41],0.92798202894023
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Acute gastritis,17614,72,0.79 [0.46-1.38],0.410926263466922
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Acute pancreatitis,21502,140,1.02 [0.74-1.41],0.8942921492529846
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Acute peritonitis,22973,73,1.01 [0.65-1.59],0.9577792683819798
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Alcoholic liver disease,22714,30,0.38 [0.13-1.13],0.0822648077227589
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Barrett oesophagus,17839,297,1.18 [0.98-1.43],0.0847120294669186
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC)",21430,68,1.20 [0.82-1.76],0.3420250211092208
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC), with reimbursement 202",23104,68,1.21 [0.82-1.77],0.3352150626760052
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Cholecystitis,21515,153,1.12 [0.85-1.48],0.4214749620794332
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Cholelithiasis,22385,1023,1.04 [0.93-1.17],0.4970892227801613
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Chronic gastritis,17831,289,0.89 [0.69-1.14],0.3536487087424498
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Chronic pancreatitis,21395,33,0.47 [0.17-1.26],0.1340237965229881
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,"Cirrhosis of liver, NAS",23388,63,0.99 [0.60-1.64],0.9802289656953548
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Coeliac disease,22144,128,1.46 [1.18-1.81],0.0004283503410415
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Collagenous colitis,21838,95,0.76 [0.46-1.24],0.2676845215169664
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,23333,134,1.20 [0.91-1.58],0.1852802348117362
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Constipation,23166,1453,0.96 [0.86-1.07],0.4331271776235299
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Crohn disease,21812,69,1.15 [0.77-1.72],0.4911387307100225
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",23154,49,1.28 [0.84-1.93],0.2493193881924764
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Crohn's disease NAS,21816,73,1.27 [0.90-1.79],0.1665591666022408
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Dental caries,22750,202,0.88 [0.65-1.19],0.4139297183992669
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,22058,2092,0.98 [0.90-1.07],0.6470049859990434
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Diseases of appendix,23327,158,1.00 [0.73-1.36],0.9954621369117672
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Diseases of liver,23372,688,1.03 [0.90-1.19],0.6499511609351359
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",21490,3948,0.99 [0.93-1.06],0.8377636301803559
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",23060,512,1.06 [0.90-1.24],0.5058463543581131
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Diseases of peritoneum,23350,450,1.15 [0.98-1.34],0.0919378350593353
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,22649,101,1.26 [0.94-1.71],0.1256534033937898
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Diseases of salivary glands,22521,55,1.16 [0.74-1.82],0.5167448155643126
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Diseases of the digestive system,23203,1187,1.06 [0.95-1.18],0.2954941395468504
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Diseases of tongue,22526,89,1.20 [0.85-1.69],0.3034853541436225
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",22723,1361,1.02 [0.92-1.13],0.7417885903244641
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,19480,2737,0.98 [0.91-1.06],0.6303155291719016
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Duodenal ulcer,17658,116,0.60 [0.37-0.99],0.0440196516260914
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",23408,96,0.58 [0.34-1.01],0.0537336157110008
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,23369,57,0.76 [0.41-1.42],0.3895101530907247
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Fibrosis and cirrhosis of liver,22764,80,0.91 [0.57-1.46],0.6958440624927855
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,16841,98,1.07 [0.74-1.53],0.73121873785359
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Functional dyspepsia,18114,572,0.91 [0.76-1.09],0.3106696370703281
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Gastric ulcer,17839,297,1.01 [0.80-1.26],0.946343067053413
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,19929,2387,1.00 [0.92-1.08],0.9873366631881698
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,17951,409,0.89 [0.72-1.10],0.2898541419235485
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,18365,7206,1.02 [0.97-1.06],0.4534078880106507
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,GI-bleeding,22959,943,1.00 [0.88-1.14],0.9998230108581572
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Gingivitis and periodontal diseases,22610,62,0.77 [0.42-1.40],0.3978656420943318
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Haemorrhoids and perianal venous thrombosis,17577,1084,1.05 [0.94-1.17],0.419719913358331
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,"Hepatic failure, not elsewhere classified",22716,32,1.12 [0.60-2.09],0.7303248065642944
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Hernia,22432,2466,1.01 [0.93-1.09],0.8593472555535628
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Impacted teeth,23377,52,0.78 [0.41-1.48],0.441964147829316
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Impaction of intestines,16801,58,0.74 [0.39-1.39],0.3488956472213105
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Inguinal hernia,20115,149,1.19 [0.91-1.56],0.209456452461623
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Intestinal adhesions without obstruction,16829,86,0.98 [0.65-1.50],0.9378630144717952
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Intestinal malabsorption,22170,154,1.40 [1.14-1.72],0.0013499183644644
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,17435,692,0.94 [0.80-1.09],0.4108345323350199
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Nonalcoholic fatty liver disease,23445,297,0.96 [0.76-1.21],0.7321740456502195
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,22447,704,0.92 [0.79-1.08],0.3103749632347414
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,22683,940,0.93 [0.81-1.07],0.3073164120864013
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Oesophageal obstruction,17674,132,1.25 [0.95-1.63],0.110765360006558
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Oesophagitis,18032,490,1.05 [0.89-1.25],0.5449059272396384
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,23418,139,0.86 [0.59-1.25],0.4293551794969502
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Other and unspecified abdominal hernia,20017,51,1.20 [0.75-1.91],0.4546716250400388
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,17826,1083,0.92 [0.81-1.04],0.192644541068866
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,21611,249,1.12 [0.90-1.39],0.3306623485471285
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Other diseases of gallbladder,21521,159,0.96 [0.70-1.33],0.8223951159170737
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Other diseases of intestine,18101,1358,0.98 [0.88-1.09],0.7074029930324629
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Other diseases of intestines,21606,4863,0.97 [0.92-1.03],0.3445710580600575
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,22531,200,0.74 [0.52-1.04],0.0825034503359034
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Other diseases of liver,23258,574,1.05 [0.90-1.22],0.5636991512918572
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,18050,508,1.20 [1.04-1.38],0.0121513867357102
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Other diseases of pancreas,21493,131,0.74 [0.48-1.13],0.1648315550067487
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,23293,393,1.15 [0.97-1.36],0.1054636505105188
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,18475,933,1.05 [0.93-1.19],0.4375724354840862
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,22975,959,1.01 [0.89-1.15],0.8587935713952394
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,22700,152,1.35 [1.08-1.69],0.0086934899867237
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,18245,1502,0.96 [0.87-1.06],0.4359054112789762
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),19334,1792,1.03 [0.94-1.12],0.5607101778948718
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Other inflammatory liver diseases,22772,88,1.02 [0.68-1.54],0.9108836555790804
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,22577,834,0.92 [0.80-1.07],0.2690481466486834
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",17026,283,1.04 [0.83-1.29],0.7494123760535321
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,23361,66,1.06 [0.68-1.66],0.7938556053802371
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,17167,424,0.93 [0.76-1.14],0.4804582794181794
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",22134,118,1.06 [0.75-1.48],0.7486624440500653
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Recurring oral aphthae,23447,64,1.29 [0.90-1.85],0.1710862708711464
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Stomatitis and related lesions,22550,116,1.09 [0.78-1.53],0.5944587605097883
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Toxic colitis,21797,54,1.11 [0.69-1.79],0.6637506376855271
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,17749,207,1.06 [0.81-1.37],0.6834515875887517
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Ulcerative colitis,21880,137,1.04 [0.75-1.43],0.8241835406900425
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",21856,113,1.14 [0.83-1.57],0.4085832034406812
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Umbilical hernia,20113,147,1.36 [1.08-1.71],0.0088971374398014
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Vascular disorders of the intestines,16906,163,1.07 [0.81-1.43],0.6201955649324797
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Ventral hernia,20178,212,1.17 [0.92-1.47],0.197845015650316
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Volvulus,16816,73,0.72 [0.41-1.27],0.2585141765703693
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Actinic keratosis,23381,214,0.89 [0.66-1.19],0.4199345236933058
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Arthropathic psoriasis,23176,73,1.08 [0.71-1.64],0.7300741968849093
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,21712,193,0.94 [0.70-1.26],0.677883847388451
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,22992,540,0.91 [0.75-1.09],0.2946852905409027
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",22580,128,1.03 [0.74-1.44],0.8438660352711249
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Decubitus ulcer and pressure area,21786,267,1.06 [0.84-1.33],0.6228339125785896
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis,23183,243,0.97 [0.75-1.25],0.7898488863305444
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,23357,417,0.93 [0.76-1.14],0.5086271834848695
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis due to substances taken internally,22982,42,0.84 [0.42-1.68],0.6254072187845441
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,22078,2701,0.97 [0.90-1.05],0.427789648085958
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,23068,403,0.97 [0.80-1.19],0.795479880622023
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,22941,276,0.92 [0.71-1.18],0.494614753097214
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,23179,727,0.93 [0.80-1.08],0.3498109387651587
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,"Lichen planus, including avohilmo",23436,67,0.88 [0.52-1.49],0.6265317031040316
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Lupus erythematosus,21605,86,1.04 [0.70-1.55],0.8441809901264478
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,22705,40,1.54 [1.10-2.16],0.0115906017443882
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified dermatitis,23169,229,0.98 [0.75-1.27],0.8537335321630826
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,21875,356,1.06 [0.88-1.29],0.5325559952712644
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified epidermal thickening,21565,46,0.43 [0.18-1.03],0.0573144679238268
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified erythematous conditions,23369,68,0.93 [0.56-1.54],0.7650003177087206
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified local infections of skin and subcutaneous tissue,22581,129,0.85 [0.58-1.26],0.4277203860335552
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,23250,147,1.00 [0.72-1.38],0.9915303366379564
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Other contact dermatitis,22982,42,0.49 [0.20-1.17],0.1089724981240488
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of pigmentation,21573,54,0.72 [0.37-1.41],0.3377116798854907
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,22870,1351,1.00 [0.90-1.12],0.9480626474919268
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",21906,387,1.06 [0.88-1.27],0.5609661992923201
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Other epidermal thickening,21567,48,0.51 [0.23-1.15],0.1043414402364012
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,23380,277,0.95 [0.75-1.22],0.7044405432005074
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Pruritus,23014,74,1.07 [0.71-1.63],0.7429072619231918
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,23316,213,1.00 [0.76-1.30],0.9783601879012948
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,23407,240,0.90 [0.69-1.19],0.4711484216592795
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,21660,141,0.81 [0.56-1.20],0.2949662874936718
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,21742,223,0.83 [0.61-1.12],0.2287801401169051
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,23396,229,0.89 [0.67-1.18],0.417930120151906
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,"Ulcer of lower limb, not elsewhere classified",21686,167,1.12 [0.85-1.47],0.4201589750216753
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Urticaria and erythema,23426,125,1.02 [0.72-1.43],0.9170428905346878
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Adhesive capsulitis of shoulder,20014,112,0.67 [0.41-1.07],0.0942913322392358
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,21302,5467,0.99 [0.94-1.04],0.6095879985432855
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,20124,4289,0.99 [0.93-1.05],0.7724762568749922
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Bursitis of shoulder,19967,65,0.91 [0.54-1.52],0.7148572948300462
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,20128,133,0.75 [0.50-1.14],0.1768105974772993
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,20177,182,0.97 [0.72-1.30],0.8153455140111909
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Chondropathies,23213,98,1.08 [0.76-1.55],0.6626883333074334
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Collapsed vertebra, not elsewhere classified",20096,101,0.47 [0.26-0.83],0.0091212404168603
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,17027,1192,1.03 [0.93-1.15],0.5527261628112974
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",23319,198,1.04 [0.80-1.37],0.7601497096458043
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,20496,501,1.02 [0.86-1.21],0.819784137424675
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,19703,6946,0.98 [0.94-1.03],0.5119166669128308
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,21025,114,1.04 [0.73-1.47],0.8290520594026907
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of muscles,20016,114,1.14 [0.83-1.56],0.4046530557578226
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,20494,592,0.84 [0.70-1.01],0.0649046130408902
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,22575,2580,0.94 [0.87-1.02],0.1541458901835952
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,20057,155,0.77 [0.53-1.12],0.1662503671259355
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibromyalgia,20236,334,1.03 [0.84-1.26],0.7835902950443738
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,20051,149,0.88 [0.62-1.25],0.4846023044978537
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Giant cell arteritis,22605,95,1.08 [0.75-1.58],0.6718523174323021
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,17458,1623,1.02 [0.93-1.12],0.667569442310553
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,16015,180,0.75 [0.52-1.07],0.1141368060958239
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",23443,177,0.76 [0.53-1.09],0.139981519513305
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,15925,90,1.17 [0.83-1.65],0.3835112605388002
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),16329,494,0.97 [0.81-1.16],0.7243939681389933
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,20192,290,0.98 [0.78-1.23],0.8426905812367494
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,16388,553,1.03 [0.88-1.21],0.726890136743513
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Kyphosis,20053,58,0.82 [0.45-1.50],0.5241833734760848
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,20612,617,0.96 [0.82-1.13],0.6505325882555595
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,20284,289,0.99 [0.79-1.25],0.9470994086049876
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,16349,514,1.00 [0.85-1.19],0.955848379393576
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Myalgia,19975,73,1.00 [0.64-1.56],0.9885216510470034
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Neuralgia and neuritis, unspecified",19962,60,1.14 [0.74-1.76],0.5434795152686809
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteomyelitis,20953,42,0.81 [0.40-1.65],0.5682426477872917
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,23051,2140,0.97 [0.89-1.05],0.4335616057463498
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,22456,1545,0.97 [0.87-1.07],0.5404641977230464
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",23274,503,0.97 [0.81-1.15],0.6984388989369307
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,18447,2612,0.96 [0.88-1.03],0.2580879581422801
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other articular cartilage disorders,15896,61,0.77 [0.42-1.39],0.3812067024449261
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other bursopathies,19991,89,0.87 [0.55-1.38],0.5621709415635257
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other crystal arthropathies,15877,42,0.77 [0.37-1.61],0.4829358555267095
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),16009,174,1.01 [0.76-1.35],0.9317924794403096
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,21163,252,1.00 [0.79-1.28],0.9741034599469724
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone density and structure,21394,483,0.99 [0.83-1.18],0.8783909679575663
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of the musculoskeletal system and connective tissue,23431,93,0.93 [0.61-1.44],0.757626719157532
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",21745,1750,0.92 [0.83-1.01],0.0917458031043212
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,20014,112,1.12 [0.81-1.55],0.4901568149861256
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),16034,199,0.99 [0.75-1.30],0.95081968501627
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,20696,701,0.95 [0.81-1.10],0.4786908128115137
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,18023,2188,1.00 [0.93-1.09],0.9232716546098012
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other necrotizing vasculopathies,22625,115,1.18 [0.87-1.61],0.2832024997233339
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other psoriatic arthropathies,23437,72,1.26 [0.89-1.79],0.1939363596615838
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,19967,65,1.16 [0.78-1.75],0.4619047666053449
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",21168,1266,0.96 [0.86-1.07],0.4624725852008745
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified disorders of muscle,19970,68,1.08 [0.70-1.67],0.7387726173715196
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,17541,1706,0.99 [0.90-1.08],0.7789801621978769
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,21034,123,0.83 [0.56-1.25],0.3763940393605092
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies,19951,49,0.59 [0.28-1.25],0.1693363710160483
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified inflammatory spondylopathies,20164,169,1.03 [0.77-1.38],0.8373755900367512
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,20392,490,1.08 [0.92-1.27],0.3538708817207383
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,22955,445,1.05 [0.88-1.25],0.6051433017081667
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,20551,556,0.81 [0.67-0.99],0.0356373342735772
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,23286,486,0.98 [0.82-1.17],0.8424289823258001
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified seropositive rheumatoid arthritis,23433,58,0.86 [0.48-1.54],0.6186464868754913
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,20096,194,0.99 [0.75-1.31],0.9332913702967942
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,17957,782,0.93 [0.80-1.08],0.3302738259090119
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,20472,570,0.88 [0.73-1.05],0.1612145258838936
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],20008,106,0.78 [0.49-1.23],0.2788818260618043
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Polyarthritis, unspecified",15906,71,1.44 [1.08-1.91],0.012552304737897
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,18097,2262,0.99 [0.91-1.07],0.7270882474070958
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,16557,722,0.84 [0.71-0.99],0.0369195259208619
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polymyalgia rheumatica,22764,254,0.92 [0.70-1.21],0.5394374173479093
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Postprocedural musculoskeletal disorders, not elsewhere classified",23405,67,0.95 [0.57-1.57],0.8339070498228565
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Primary gonarthrosis, bilateral",21480,47,1.06 [0.61-1.85],0.833077224749387
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Psoriatic arthropathies,15908,73,1.26 [0.88-1.78],0.2038242110400835
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Radiculopathy,20089,94,0.69 [0.41-1.15],0.1557385812348961
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,16342,507,0.95 [0.79-1.13],0.5390307299396455
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,20179,277,0.84 [0.64-1.10],0.2019274573558627
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,20242,247,0.97 [0.76-1.25],0.8316169396582624
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Scoliosis,20233,238,1.03 [0.81-1.32],0.8166553388979588
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Seronegative rheumatoid arthritis,18074,75,0.99 [0.62-1.57],0.9580704164766568
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Seropositive rheumatoid arthritis, wide",23438,63,0.85 [0.48-1.49],0.5606825862772429
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,20448,546,0.90 [0.75-1.08],0.2401464073979237
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sicca syndrome [Sj¬ögren],22655,145,1.20 [0.92-1.56],0.1828707175682402
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,22323,2421,0.94 [0.86-1.02],0.1292725969024731
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",20036,134,0.87 [0.59-1.26],0.4546840870531995
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,20478,483,0.89 [0.74-1.09],0.2591361133142559
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondyloarthritis,21955,218,0.97 [0.74-1.28],0.8494979732334474
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylolisthesis/Spondylolysis,20208,213,1.12 [0.88-1.42],0.3500919734287243
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,21480,1485,0.92 [0.82-1.02],0.115671308027663
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,21006,1011,0.93 [0.81-1.06],0.2622530661904844
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Synovial cyst of popliteal space [Baker],19957,55,0.97 [0.57-1.65],0.8981395991435992
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,22716,206,1.33 [1.10-1.61],0.0034962330290675
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,20073,171,0.83 [0.59-1.17],0.2892613646775672
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trochanteric bursitis,20016,114,1.03 [0.72-1.47],0.8687487969175346
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Wrist or foot drop (acquired),15877,42,0.74 [0.35-1.55],0.420913543793694
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Acute renal failure,22627,1026,0.98 [0.87-1.11],0.766813776525356
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Adenomyosis (Endometriosis of uterus),17527,85,0.75 [0.45-1.25],0.2736239319596443
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Benign mammary dysplasia,22857,97,0.91 [0.60-1.39],0.6733865465110538
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,23323,199,1.16 [0.92-1.47],0.20399929004732
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Calculus of lower urinary tract,23147,23,1.33 [0.76-2.34],0.3222098846331985
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,22745,1144,0.99 [0.88-1.11],0.8144838832877528
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Chronic nephritic syndrome,23316,58,1.03 [0.62-1.70],0.9115335510210538
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Cyst of kidney,23290,198,1.10 [0.86-1.42],0.4544956785361869
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Cystitis,20714,213,1.07 [0.83-1.37],0.6178323220376616
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Dialysis,21646,45,1.44 [1.01-2.05],0.0411061389891383
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Disorders of breast,23040,280,0.84 [0.64-1.09],0.1967261938845153
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Endometriosis,17590,148,0.82 [0.57-1.18],0.2838451482308258
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,"Excessive, frequent and irregular menstruation",17776,334,0.97 [0.78-1.20],0.768751766282333
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Female genital prolapse,18302,860,1.03 [0.91-1.18],0.6405313731475387
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,18201,4230,0.97 [0.92-1.04],0.3954812102641813
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Glomerular disorders in diseases classified elsewhere,23309,51,1.04 [0.61-1.75],0.8929665719320996
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Hydronephrosis,21486,176,1.02 [0.77-1.36],0.8958636873068769
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of female pelvic organs,22978,339,1.08 [0.89-1.31],0.4549697258020995
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Irregular menses,23056,107,0.82 [0.54-1.26],0.3649613039177735
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Menorrhagia,17705,263,1.06 [0.85-1.31],0.6307189099072092
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,20568,67,0.91 [0.54-1.52],0.7179143000143366
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Noninflammatory disorders of female genital tract,19514,2072,0.95 [0.87-1.04],0.2702272833482119
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Other abnormal uterine and vaginal bleeding,17557,115,0.69 [0.43-1.09],0.111928962442911
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,"Other chronic cystitis, drug-induced",23446,56,0.93 [0.53-1.62],0.795582008179954
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,"Other cystitis, drug-induced",23446,65,1.10 [0.71-1.71],0.6791693700775541
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,22381,1880,0.98 [0.90-1.08],0.7134194174076673
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,20907,406,1.02 [0.84-1.23],0.8638900387187203
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Other disorders of breast,22858,98,0.77 [0.48-1.24],0.2908611144078164
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,23407,315,1.08 [0.88-1.32],0.471059614807403
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Other disorders of the genitourinary system,23405,76,1.25 [0.88-1.77],0.2114587902233829
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,22106,1605,0.97 [0.88-1.07],0.5235876299017508
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Other female pelvic inflammatory diseases,22814,175,1.04 [0.78-1.37],0.800610806002866
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of cervix uteri,17577,135,0.96 [0.68-1.36],0.8245229217058039
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,"Other noninflammatory disorders of uterus, except cervix",17773,331,0.74 [0.57-0.97],0.0282952324563631
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vagina,17539,97,1.13 [0.79-1.61],0.5032908753279985
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vulva and perineum,17616,174,0.67 [0.46-0.99],0.0452049893935543
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,21529,219,1.06 [0.83-1.35],0.6419910588015393
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Other specified disorders of kidney and ureter,23194,102,1.04 [0.71-1.51],0.846960569565941
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Ovarian cyst,17702,260,1.15 [0.94-1.42],0.1784954357604871
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Pain and other conditions associated with female genital organs and menstrual cycle,17532,90,1.01 [0.67-1.51],0.9662684609638972
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Polyp of the female genital tract,17979,537,0.90 [0.75-1.08],0.2771916340117167
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Postmenopausal atrophic vaginitis,17579,137,0.47 [0.29-0.77],0.0026822483677561
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Postmenopausal bleeding,17937,495,0.90 [0.75-1.09],0.292520554242786
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Recurrent and persistent haematuria,23292,34,0.59 [0.24-1.48],0.2648289431859512
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,23308,1998,1.00 [0.92-1.09],0.9616069138732456
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,"Tubulo-interstitial nephritis, not specified as acute or chronic",21453,143,1.13 [0.85-1.49],0.4111329210164466
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,21678,77,1.05 [0.69-1.60],0.8166780872901873
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,23155,31,0.70 [0.29-1.70],0.4328651701843033
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Urethral stricture,20627,126,1.10 [0.81-1.50],0.5424669454665448
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Urolithiasis,23353,229,1.14 [0.91-1.43],0.2384987716941566
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Uterine polyps,17560,118,1.03 [0.73-1.45],0.8612953525087665
